174 related articles for article (PubMed ID: 30032944)
1. Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.
Crits-Christoph P; Wadden S; Gaines A; Rieger A; Gallop R; McKay JR; Gibbons MBC
J Subst Abuse Treat; 2018 Sep; 92():46-50. PubMed ID: 30032944
[TBL] [Abstract][Full Text] [Related]
2. Using a data science approach to predict cocaine use frequency from depressive symptoms.
Suchting R; Vincent JN; Lane SD; Green CE; Schmitz JM; Wardle MC
Drug Alcohol Depend; 2019 Jan; 194():310-317. PubMed ID: 30472571
[TBL] [Abstract][Full Text] [Related]
3. Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals.
Miguel AQC; Madruga CS; Cogo-Moreira H; Yamauchi R; Simões V; Ribeiro A; da Silva CJ; Fruci A; McDonell M; McPherson S; Roll JM; Laranjeira RR
Exp Clin Psychopharmacol; 2017 Dec; 25(6):466-472. PubMed ID: 29251975
[TBL] [Abstract][Full Text] [Related]
4. Cocaine abusers with and without alcohol dependence respond equally well to contingency management treatments.
Rash CJ; Alessi SM; Petry NM
Exp Clin Psychopharmacol; 2008 Aug; 16(4):275-81. PubMed ID: 18729681
[TBL] [Abstract][Full Text] [Related]
5. Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use.
Alessi SM; Rash C; Petry NM
Drug Alcohol Depend; 2011 Oct; 118(1):62-7. PubMed ID: 21440999
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity effects on cocaine dependence treatment and examination of reciprocal relationships between abstinence and depression.
Milby JB; Conti K; Wallace D; Mennemeyer S; Mrug S; Schumacher JE
J Consult Clin Psychol; 2015 Feb; 83(1):45-55. PubMed ID: 25329491
[TBL] [Abstract][Full Text] [Related]
7. Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children.
Schottenfeld RS; Moore B; Pantalon MV
Drug Alcohol Depend; 2011 Oct; 118(1):48-55. PubMed ID: 21454024
[TBL] [Abstract][Full Text] [Related]
8. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
[TBL] [Abstract][Full Text] [Related]
9. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
[TBL] [Abstract][Full Text] [Related]
10. Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.
Wardle MC; Vincent JN; Suchting R; Green CE; Lane SD; Schmitz JM
J Subst Abuse Treat; 2017 Jan; 72():32-39. PubMed ID: 27646197
[TBL] [Abstract][Full Text] [Related]
11. Contingency management improves outcomes in cocaine-dependent outpatients with depressive symptoms.
García-Fernández G; Secades-Villa R; García-Rodríguez O; Peña-Suárez E; Sánchez-Hervás E
Exp Clin Psychopharmacol; 2013 Dec; 21(6):482-9. PubMed ID: 24080020
[TBL] [Abstract][Full Text] [Related]
12. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
[TBL] [Abstract][Full Text] [Related]
13. A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence.
Farronato NS; Dürsteler-Macfarland KM; Wiesbeck GA; Petitjean SA
J Addict Dis; 2013; 32(3):274-87. PubMed ID: 24074193
[TBL] [Abstract][Full Text] [Related]
14. Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.
Miguel AQC; Kiluk BD; Babuscio TA; Nich C; Mari JJ; Carroll KM
Drug Alcohol Depend; 2019 May; 198():126-132. PubMed ID: 30921648
[TBL] [Abstract][Full Text] [Related]
15. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
[TBL] [Abstract][Full Text] [Related]
16. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: post-intervention outcomes.
DeFulio A; Silverman K
Addiction; 2011 May; 106(5):960-7. PubMed ID: 21226886
[TBL] [Abstract][Full Text] [Related]
17. Behavioral activation and smoking cessation outcomes: The role of depressive symptoms.
Martínez-Vispo C; López-Durán A; Senra C; Rodríguez-Cano R; Fernández Del Río E; Becoña E
Addict Behav; 2020 Mar; 102():106183. PubMed ID: 31809878
[TBL] [Abstract][Full Text] [Related]
18. Association of depressive symptoms during abstinence with the subjective high produced by cocaine.
Uslaner J; Kalechstein A; Richter T; Ling W; Newton T
Am J Psychiatry; 1999 Sep; 156(9):1444-6. PubMed ID: 10484960
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of contingency management for cocaine dependence treatment: a review of the evidence.
Schierenberg A; van Amsterdam J; van den Brink W; Goudriaan AE
Curr Drug Abuse Rev; 2012 Dec; 5(4):320-31. PubMed ID: 23244344
[TBL] [Abstract][Full Text] [Related]
20. Cocaine-using substance abuse treatment patients with and without HIV respond well to contingency management treatment.
Burch AE; Rash CJ; Petry NM
J Subst Abuse Treat; 2017 Jun; 77():21-25. PubMed ID: 28476266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
